ATE2442T1 - Verfahren zur herstellung von interferon und dabei verwendete kulturmediumzusammensetzung. - Google Patents
Verfahren zur herstellung von interferon und dabei verwendete kulturmediumzusammensetzung.Info
- Publication number
- ATE2442T1 ATE2442T1 AT80400416T AT80400416T ATE2442T1 AT E2442 T1 ATE2442 T1 AT E2442T1 AT 80400416 T AT80400416 T AT 80400416T AT 80400416 T AT80400416 T AT 80400416T AT E2442 T1 ATE2442 T1 AT E2442T1
- Authority
- AT
- Austria
- Prior art keywords
- interferon
- preparation
- culture medium
- composition used
- medium composition
- Prior art date
Links
- 102000014150 Interferons Human genes 0.000 title abstract 2
- 108010050904 Interferons Proteins 0.000 title abstract 2
- 229940079322 interferon Drugs 0.000 title abstract 2
- 239000001963 growth medium Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 102000008100 Human Serum Albumin Human genes 0.000 abstract 2
- 108091006905 Human Serum Albumin Proteins 0.000 abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 235000021120 animal protein Nutrition 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/025,305 US4198479A (en) | 1979-03-30 | 1979-03-30 | Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells |
EP80400416A EP0017570B1 (de) | 1979-03-30 | 1980-03-28 | Verfahren zur Herstellung von Interferon und dabei verwendete Kulturmediumzusammensetzung |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE2442T1 true ATE2442T1 (de) | 1983-03-15 |
Family
ID=21825245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT80400416T ATE2442T1 (de) | 1979-03-30 | 1980-03-28 | Verfahren zur herstellung von interferon und dabei verwendete kulturmediumzusammensetzung. |
Country Status (6)
Country | Link |
---|---|
US (1) | US4198479A (de) |
EP (1) | EP0017570B1 (de) |
JP (1) | JPS55131399A (de) |
AT (1) | ATE2442T1 (de) |
DE (1) | DE3061854D1 (de) |
DK (1) | DK133780A (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6410697B1 (en) * | 1979-04-20 | 2002-06-25 | Schering Corporation | Process for purifying human leukocyte interferon |
US4357422A (en) * | 1980-08-14 | 1982-11-02 | Massachusetts Institute Of Technology | Method of enhancing interferon production |
JPS6045849B2 (ja) * | 1980-08-25 | 1985-10-12 | 林原 健 | ヒトエリトロポエチンの製造方法 |
JPS5774085A (en) * | 1980-10-25 | 1982-05-10 | Ajinomoto Co Inc | Culture medium for cells originating from lymphocytes |
JPS57194787A (en) * | 1981-05-28 | 1982-11-30 | Ajinomoto Co Inc | Culture medium for animal cell |
US4452893A (en) * | 1981-08-03 | 1984-06-05 | Cutter Laboratories, Inc. | Cell growth medium supplement |
EP0082481B2 (de) * | 1981-12-23 | 1990-09-12 | Schering Corporation | Stabilisierte alpha-Interferon-Zusammensetzungen und ihre Herstellung |
US4490357A (en) * | 1981-12-30 | 1984-12-25 | Skurkovich Simon V | Simplified in-vitro interferon production |
US4758510A (en) * | 1981-12-30 | 1988-07-19 | S.V.S. Laboratories, Inc. | Simplified in-vitro interferon production |
JPS58209993A (ja) * | 1982-05-31 | 1983-12-07 | Mochida Pharmaceut Co Ltd | インタ−フエロンの産生方法 |
FR2572093A1 (fr) * | 1984-10-22 | 1986-04-25 | Anda Biolog | Nouveau milieu de culture cellulaire contenant des cellules de rate humaine, procede de culture utilisant ce milieu de culture, lignees de cellules lymphoblastoides obtenues, application a la production d'interferon, procede de preparation d'interferon et interferon ainsi produit |
FR2600076A1 (fr) * | 1986-06-12 | 1987-12-18 | Fond Ctre Nal Transfusion | Milieu de culture comportant de l'albumine humaine, procede de preparation d'un produit injectable a partir de ce milieu, produit obtenu et son utilisation, composition obtenue |
US6231881B1 (en) | 1992-02-24 | 2001-05-15 | Anton-Lewis Usala | Medium and matrix for long-term proliferation of cells |
US6352707B1 (en) | 1992-02-24 | 2002-03-05 | Anton-Lewis Usala | Transplant encapsulation in a hydrogel matrix to obscure immune recognition |
US6207437B1 (en) * | 1996-03-11 | 2001-03-27 | Genencor International, Inc. | Crystalline protease and method for producing same |
AU2001265151A1 (en) * | 2000-05-31 | 2001-12-11 | Encelle, Inc. | Method of stimulating hair growth |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3800035A (en) * | 1971-12-07 | 1974-03-26 | Smithkline Corp | Production of interferon from human leukocytes in the absence of serum |
GB1464939A (en) * | 1974-01-11 | 1977-02-16 | Anvar | Process for the production of interferon |
JPS5251009A (en) * | 1975-10-17 | 1977-04-23 | Morinaga Milk Ind Co Ltd | Method of producing drug for treating marrow leukemia |
DE2724918A1 (de) * | 1977-06-02 | 1978-12-14 | Thomae Gmbh Dr K | Gewinnung und reinigung von humaninterferon |
DK485977A (da) * | 1977-11-01 | 1979-05-02 | Ess Foodeksport | Fremgangsmaade til udvinding af et biologisk aktivt materiale fra svineblodfraktioner |
DE2821466A1 (de) * | 1978-05-17 | 1979-11-29 | Thomae Gmbh Dr K | Verbessertes verfahren zur herstellung von humaninterferon |
DE2961658D1 (en) * | 1978-05-17 | 1982-02-18 | Thomae Gmbh Dr K | Process for preparing human interferon |
-
1979
- 1979-03-30 US US06/025,305 patent/US4198479A/en not_active Expired - Lifetime
-
1980
- 1980-03-28 EP EP80400416A patent/EP0017570B1/de not_active Expired
- 1980-03-28 DE DE8080400416T patent/DE3061854D1/de not_active Expired
- 1980-03-28 AT AT80400416T patent/ATE2442T1/de not_active IP Right Cessation
- 1980-03-28 DK DK133780A patent/DK133780A/da not_active Application Discontinuation
- 1980-03-29 JP JP4113980A patent/JPS55131399A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US4198479A (en) | 1980-04-15 |
JPS55131399A (en) | 1980-10-13 |
EP0017570A1 (de) | 1980-10-15 |
DK133780A (da) | 1980-10-01 |
DE3061854D1 (en) | 1983-03-17 |
EP0017570B1 (de) | 1983-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE2442T1 (de) | Verfahren zur herstellung von interferon und dabei verwendete kulturmediumzusammensetzung. | |
BR8301918A (pt) | Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase | |
ATE96174T1 (de) | Verfahren zur herstellung von avermectine-b und die verwendeten kulturen. | |
DE69033032T2 (de) | Integriertes zellkultur-proteinreinigungssystem zur automatisierten herstellung und reinigung von zellkulturprodukten | |
ATE43635T1 (de) | Verfahren zur herstellung von interferon und expressionsvektoren dafuer. | |
DE3280479T2 (de) | Rekombinante DNS-Mittel und Verfahren | |
ATA564080A (de) | Verfahren zur herstellung von 4'-epidaunorubicin und 3',4'-diepidaunorubicin | |
ATE68826T1 (de) | Verfahren zur herstellung von reifem, menschlichem serum-albumin. | |
ATE71658T1 (de) | Verfahren zur herstellung von humanlysozym. | |
ATE1241T1 (de) | Verfahren zur herstellung von 4,5-perfluor-1,3-dioxolanen. | |
DE3886213D1 (de) | Verfahren zur Herstellung von Antioxidant-Zubereitungen. | |
DK12990D0 (da) | Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf | |
ATE76636T1 (de) | Verfahren zur herstellung von benzoesaeure und ihren salzen. | |
ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
ATE2327T1 (de) | Pyrazincarboxamide, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
DE3888317D1 (de) | Verfahren zur Herstellung von Phosphorsäurederivaten und Zwischenprodukten. | |
ATA335178A (de) | Verfahren zur herstellung von neuen 1-acyl-2- hydroxy-1,3-diaminopropanen und deren salzen | |
DE3688854T2 (de) | Verfahren zur Herstellung von Polythiobisphenolen und Verfahren zur Herstellung von Mercaptophenolen durch Hydrogenolyse der Polythiobisphenole. | |
ATE94905T1 (de) | Verfahren zur herstellung von fremdproteinen in streptomyceten. | |
PT65644A (de) | Verfahren zur herstellung von 1,3-gleichsubstituierten triazin-2,4-dionen sowie deren verwendung als insektizide | |
ATE51154T1 (de) | Antithrombogenes, nichtcalcifizierendes material und ein verfahren zur herstellung von gegenstaenden fuer medizinische zwecke. | |
PT80121B (de) | Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens | |
AT378915B (de) | Verfahren zur herstellung von antihypertensiven pharmazeutischen zubereitungen | |
DD133231A1 (de) | Verfahren zur herstellung von peptiden,proteinen und proteinsequenzen | |
ATE98292T1 (de) | Verfahren zur herstellung von antioxidantzubereitungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REZ | Deleted due to withdrawal |